Raymond James Financial’s Adient ADNT Stock Holding History

Raymond James Financial’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,223	Closed	-$62.7K	–	4974
2025 Q2	$62.7K	Buy	+3,223	New	+$47.6K	﹤0.01%	5090

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

Raymond James Financial's ADNT Position: Q3 2025 in Review

Raymond James Financial sold out of Adient (ADNT) in Q3 2025, closing a stake of 3,223 shares — an estimated $62.7K sold.

Raymond James Financial first reported a position in ADNT in Q2 2025 and held it in 1 quarter. The position peaked at $62.7K in Q2 2025. 287 funds tracked by Wall St. Rank hold ADNT as of Q3 2025.

Raymond James Financial reported no remaining Adient position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 3,223 Adient shares in Q3 2025, an estimated $62.7K.
Raymond James Financial first reported a position in Adient in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Adient position peaked at $62.7K in Q2 2025.
287 funds tracked by Wall St. Rank held Adient as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.